Csilla Rozsa

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Margaret Burnett, Gavin Giovannoni, 2018, The Lancet.

Contribution of different relapse phenotypes to disability in multiple sclerosis

Pierre Grammond, Patrizia Sola, Fraser Moore, 2017, Multiple sclerosis.

Predictors of long‐term disability accrual in relapse‐onset multiple sclerosis

Pierre Grammond, Patrizia Sola, Guillermo Izquierdo, 2016, Annals of neurology.

Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

Pierre Grammond, Patrizia Sola, Guillermo Izquierdo, 2016, Journal of Neurology, Neurosurgery & Psychiatry.

Towards personalized therapy for multiple sclerosis: prediction of individual treatment response

Pierre Grammond, Patrizia Sola, Murat Terzi, 2017, Brain : a journal of neurology.